The effect of intraocular dilating solution on cat endothelium

Area of Science:

• Ophthalmology
• Veterinary Medicine
• Pharmacology

Background:

• Pupillary dilatation is crucial for ophthalmic examinations and procedures.
• Achieving and maintaining adequate mydriasis can be challenging in clinical practice.
• Current mydriatic agents may have limitations or side effects.

Purpose of the Study:

• To evaluate the efficacy and safety of a dilute intraocular solution of atropine and epinephrine for inducing pupillary dilatation.
• To assess potential corneal endothelial toxicity associated with this solution in an animal model.

Main Methods:

• An intraocular solution of atropine and epinephrine was prepared at a dilute concentration.
• The solution was administered to induce pupillary dilatation.
• Corneal endothelial cell density was measured before and after administration to assess toxicity, using the cat eye as a model.

Main Results:

• The dilute intraocular solution of atropine and epinephrine proved effective in inducing pupillary dilatation.
• No significant corneal endothelial toxicity was demonstrated.
• Pre- and post-injection endothelial cell density measurements showed no adverse effects.

Conclusions:

• A dilute intraocular atropine and epinephrine solution is a safe and effective option for achieving pupillary dilatation.
• This formulation presents a viable alternative for ophthalmic procedures requiring mydriasis.
• The findings support the use of this solution with minimal risk of corneal endothelial damage.